Atara Biotherapeutics: A Gift That Keeps On Giving – Seeking Alpha
|
Atara Biotherapeutics: A Gift That Keeps On Giving
Seeking Alpha Its focus is on the innovation allogenic T–cell immunotherapies (A-TCI) to service a vast number of cancers and autoimmune diseases (as depicted in figure 2). A-TCI functions quite similar to CAR-T: both therapeutics enlighten the key regulatory cells … |
